BIOMAX IMPLEMENTS AN AI-AUGMENTED SEMANTIC SEARCH PLATFORM FOR
DSM GLOBAL RESEARCH

Royal DSM N.V., has signed a multi-year license for the Biomax semantic search technology to implement their new enterprise knowledge platform for fast, simple and comprehensive knowledge discovery. "DSM and Biomax already have a long-standing relationship and I am happy that we can expand this relationship into building a knowledge platform for DSM research," comments Dr. Marcus Remmers, CTO Royal DSM N.V. Read more...

Viscovery^® SOMine^® SUITE V7.2 RAISES THE BAR ON BIG DATA PREPROCESSING

Biomax data mining subsidiary, Viscovery, has launched version 7.2 of its Viscovery® SOMine® visual data mining suite. The new version offers improved performance in Big Data preprocessing, enhanced annotation and interpretation of explorative models on multiple semantic levels. For example, image documents, such as photos, can be displayed at the locations in the Viscovery map to which patients have been classified. Learn more...

BIOMAX AND FOUR PARTNERS KICK OFF THE IMMUNOMONITOR CANCER RESEARCH PROJECT

Biomax and four partners have started the IMMUNOMONITOR project, a EUROSTARS consortium, which aims to validate a data analysis and visualization software solution for treatment response monitoring of cancer immunotherapies. Biomax Project Manager, Dr. Imke Listerman highlighted the team’s excitement, “It's a great example of how a multi-disciplinary approach to healthcare can translate technological innovation into patient benefits." Read more…

SYMPOSIUM BRINGS NEUROIMAGING AND MOLECULAR BIOLOGY RESEARCHERS TOGETHER

Biomax organized a Satellite Symposium of the 11th FENS Forum of Neuroscience entitled "From Scanner to Bedside — What do connectome and gene expression data say about brain diseases?" Eight excellent speakers accepted the invitation. These specialists from the fields of neuroimaging, psychiatry, neurology and molecular brain science enthusiastically exchanged their ideas how patients could benefit from their latest research results. "I have never seen a symposium that brought neuroimaging and molecular biology researchers so closely together," one participant stated.